“Efficacy Comparison of Targeted Systemic Monotherapies Including Lebrikizumab for Moderate-to-Severe Atopic Dermatitis: A Network Meta-Analysis”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s313. Accessed May 17, 2025. https://skin.dermsquared.com/skin/article/view/2391.